Autres langues K2X Technology & Life Science, Inc.

Actions

KBPH

US5015722003

Marché Fermé - OTC Markets Autres places de cotation 21:30:56 22/08/2022			Varia. 5j.	Varia. 1 janv.
1 ^USD	-45,65 %		-.--%	-.--%

2022	Kyto Technology and Life Science, Inc. annonce ses résultats pour le troisième trimestre et les neuf mois se terminant le 31 décembre 2021.	CI
2021	Kyto Technology and Life Science, Inc. annonce ses résultats pour le deuxième trimestre et le semestre clos le 30 septembre 2021	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

FluidAI Medical announced that it has received CAD 15 million in funding from a group of investors	10/10/23
Infinidome Ltd. announced that it has received $9 million in funding from Hanwha Aerospace Co., Ltd., Next Gear Ventures, Honeywell Ventures, VentureIsrael, Kyto Technology and Life Science, Inc., Aston Capital Management and another investor	24/04/23
Mrinq Technologies LLP announced that it has received $2.5 million in funding from a group of investors	10/11/22
KYTO TECHNOLOGY & LIFE SCIENCE, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	09/05/22
Kyto Technology & Life Science Inc. Announces the Termination of Tender Offer	07/05/22
Kyto Technology & Life Science Inc. Announces the Termination of Tender Offer	07/05/22
KYTO TECHNOLOGY & LIFE SCIENCE, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS (form 10-Q)	22/02/22
Kyto Technology and Life Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22/02/22
KYTO TECHNOLOGY & LIFE SCIENCE, INC. : Unregistered Sale of Equity Securities (form 8-K)	09/02/22
Kyto Technology and Life Science, Inc. announced that it has received $2.620875 million in funding	04/02/22
Rhaeos, Inc. announced that it has received $2.2 million in funding from a group of investors	23/12/21
KYTO TECHNOLOGY & LIFE SCIENCE, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS (form 10-Q)	18/11/21
Kyto Technology and Life Science, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	18/11/21
KYTO TECHNOLOGY & LIFE SCIENCE, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	10/11/21
KYTO TECHNOLOGY & LIFE SCIENCE, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	12/10/21
Kyto Technology and Life Science : & LIFE SCIENCE, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS (form 10-Q/A)	06/10/21
Kyto Technology and Life Science : & LIFE SCIENCE, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS (form 10-Q)	01/10/21
Kyto Technology and Life Science, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2021	01/10/21
KYTO TECHNOLOGY & LIFE SCIENCE, INC. : Unregistered Sale of Equity Securities (form 8-K)	08/09/21
Kyto Technology and Life Science, Inc. announced that it has received $0.21 million in funding	01/09/21

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues K2X Technology & Life Science, Inc.

Actions

KBPH

US5015722003

Autres langues

Filtres